EGFR and crescentic glomerulonephritis: Glucocorticoids may suppress expression of EGFR ligands and upregulate expression of Gene 33, thereby preventing activation of EGFR and downstream pathway that leads to PEC activation and proliferation, and eventually alleviating anti-GBM crescentic glomerulonephritis.